Cargando…

Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels

P-glycoprotein (P-gp) is a crucial membrane transporter situated on the cell’s apical surface, being responsible for eliminating xenobiotics and endobiotics. P-gp modulators are compounds that can directly or indirectly affect this protein, leading to changes in its expression and function. These mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veiga-Matos, Jéssica, Morales, Ana I., Prieto, Marta, Remião, Fernando, Silva, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673607/ https://www.ncbi.nlm.nih.gov/pubmed/38005253 http://dx.doi.org/10.3390/molecules28227532

Ejemplares similares

Chiral Thioxanthones as Modulators of P-glycoprotein: Synthesis and Enantioselectivity Studies
por: Lopes, Ana, et al.
Publicado: (2018)

Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
por: Kono, Yusuke, et al.
Publicado: (2021)

Selective modulation of P-glycoprotein-mediated drug resistance
por: Bebawy, M, et al.
Publicado: (2001)

P-glycoprotein transporter in drug development
por: Prachayasittikul, Veda, et al.
Publicado: (2016)

P-glycoprotein Inhibition for Optimal Drug Delivery
por: Amin, Md. Lutful
Publicado: (2013)

P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993)

P-Glycoprotein and Drug Resistance in Systemic Autoimmune Diseases
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2014)

Robust physiologically based pharmacokinetic model of rifampicin for predicting drug–drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney
por: Asaumi, Ryuta, et al.
Publicado: (2022)

Effects of Natural Polyphenols on the Expression of Drug Efflux Transporter P-Glycoprotein in Human Intestinal Cells
por: Nabekura, Tomohiro, et al.
Publicado: (2018)

Unravelling the complex drug–drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein
por: Ledwitch, Kaitlyn V., et al.
Publicado: (2016)

Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein
por: Bikadi, Zsolt, et al.
Publicado: (2011)

Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.
por: Sakata, K., et al.
Publicado: (1991)

P‐Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer
por: Mealey, K.L., et al.
Publicado: (2015)

Reversal Effect of Oxypeucedanin on P-glycoprotein-mediated Drug Transport
por: Dong, Wei, et al.
Publicado: (2018)

Ecdysteroid Derivatives that Reverse P-Glycoprotein-Mediated Drug Resistance
por: Bortolozzi, Roberta, et al.
Publicado: (2020)

Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein
por: Pulukuri, Anunay J., et al.
Publicado: (2021)

Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein
por: Zahir, Hamim, et al.
Publicado: (2020)

Newly Synthesized Oxygenated Xanthones as Potential P-Glycoprotein Activators: In Vitro, Ex Vivo, and In Silico Studies
por: Martins, Eva, et al.
Publicado: (2019)

Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein
por: Nabekura, Tomohiro, et al.
Publicado: (2020)

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
por: Mendell, Jeanne, et al.
Publicado: (2013)

Salmonella Overcomes Drug Resistance in Tumor through P-glycoprotein Downregulation
por: Yang, Chih-Jen, et al.
Publicado: (2018)

Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs
por: Ruponen, Marika, et al.
Publicado: (2021)

Lipid environment determines the drug-stimulated ATPase activity of P-glycoprotein
por: Tran, Nghi N. B., et al.
Publicado: (2023)

Repertoire of P-glycoprotein drug transporters in the zoonotic nematode Toxocara canis
por: Jesudoss Chelladurai, Jeba R. J., et al.
Publicado: (2023)

Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
por: Versantvoort, C. H., et al.
Publicado: (1993)

Induction of P-glycoprotein expression and activity by Aconitum alkaloids: Implication for clinical drug–drug interactions
por: Wu, Jinjun, et al.
Publicado: (2016)

Novel Dihydropyrimidinone Derivatives as Potential P-Glycoprotein Modulators
por: Bijani, Sabera, et al.
Publicado: (2022)

Drug transporters in spermatogenesis: A re-evaluation of recent data on P-glycoprotein
por: Mruk, Dolores D., et al.
Publicado: (2012)

Catalytic Transitions in the Human MDR1 P-Glycoprotein Drug Binding Sites
por: Wise, John G.
Publicado: (2012)

Drug Rescue Distinguishes between Different Structural Models of Human P-Glycoprotein
por: Loo, Tip W., et al.
Publicado: (2013)

The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation
por: Senarathna, S M D K Ganga, et al.
Publicado: (2016)

Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer
por: Syed, Safiulla Basha, et al.
Publicado: (2017)

Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020)

Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein
por: Sajid, Andaleeb, et al.
Publicado: (2020)

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
por: Yoon, Sungpil, et al.
Publicado: (2021)

Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs
por: Mensah, Gershon A. K., et al.
Publicado: (2023)

Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs—Implication for Herb-Drug Interaction
por: Fasinu, Pius S., et al.
Publicado: (2017)

3,3′,4,4′,5-Pentachlorobiphenyl Inhibits Drug Efflux Through P-Glycoprotein in KB-3 Cells Expressing Mutant Human P-Glycoprotein
por: Fujise, Hiroshi, et al.
Publicado: (2004)

P-glycoprotein and chronic rhinosinusitis
por: Miyake, Marcel M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3nvh364p8iirdrd7lv6g68n8q7